Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - eplerenone - film-coated tablet - 50 milligram(s) - aldosterone antagonists; eplerenone

Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - eplerenone - film-coated tablet - 25 milligram(s) - aldosterone antagonists; eplerenone

Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - eplerenone - film-coated tablet - 50 milligram(s) - aldosterone antagonists; eplerenone

Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - eplerenone - film-coated tablet - 25 milligram(s) - aldosterone antagonists; eplerenone

Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - eplerenone - film-coated tablet - 50 milligram(s) - aldosterone antagonists; eplerenone

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - eplerenone, quantity: 25 mg - tablet, film coated - excipient ingredients: lactose monohydrate; hypromellose; purified talc; iron oxide red; microcrystalline cellulose; magnesium stearate; titanium dioxide; croscarmellose sodium; iron oxide yellow; macrogol 6000 - eplerenone is indicated to reduce the risk of: - cardiovascular death in combination with standard therapy in patients who have evidence of heart failure and left ventricular impairment within 3?14 days of an acute myocardial infarction (see clinical trials and dosage and administration). - cardiovascular mortality and morbidity in adult patients with nyha class ii (chronic) heart failure and left ventricular systolic dysfunction (lvef ? 30% or lvef ? 35% in addition to qrs duration of > 130 msec), in addition to standard optimal therapy (see clinical trials).

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - eplerenone, quantity: 50 mg - tablet, film coated - excipient ingredients: purified talc; hypromellose; iron oxide yellow; magnesium stearate; titanium dioxide; lactose monohydrate; croscarmellose sodium; macrogol 6000; iron oxide red; microcrystalline cellulose - eplerenone is indicated to reduce the risk of: - cardiovascular death in combination with standard therapy in patients who have evidence of heart failure and left ventricular impairment within 3?14 days of an acute myocardial infarction (see clinical trials and dosage and administration). - cardiovascular mortality and morbidity in adult patients with nyha class ii (chronic) heart failure and left ventricular systolic dysfunction (lvef ? 30% or lvef ? 35% in addition to qrs duration of > 130 msec), in addition to standard optimal therapy (see clinical trials).

Amerika Serikat - Inggris - NLM (National Library of Medicine)

bryant ranch prepack - eplerenone (unii: 6995v82d0b) (eplerenone - unii:6995v82d0b) - eplerenone tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular (cv) events, primarily strokes and mi. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes. control of high blood pressure should be part of comprehensive cv risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program's joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc).control of high blood pressure should be part of comprehensive cv risk management, including, as appropriate, lipid control, diabetes manag

Inggris - Inggris - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - eplerenone - oral tablet - 50mg

Inggris - Inggris - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - eplerenone - oral tablet - 50mg